DMMR-ENDOMETRIAL-CANCER-TREATMENT.COM

Last Updated: May 19, 2024

DMMR-ENDOMETRIAL-CANCER-TREATMENT.COM Summary

dmmr-endometrial-cancer-treatment.com has 4 NS records, 1 A records, 0 AAAA records, 0 MX records, and 0 TXT records. Name servers for dmmr-endometrial-cancer-treatment.com are ns-999.awsdns-60.net, ns-1601.awsdns-08.co.uk, ns-87.awsdns-10.com, ns-1070.awsdns-05.org. A records for dmmr-endometrial-cancer-treatment.com are 34.160.236.144. We have observed dmmr-endometrial-cancer-treatment.com to have 1 subdomains. A subdomain count of 1 is considered a small digital footprint. The domain's primary website is hosted on a Apache web server at 34.160.236.144 in United States. The website's description is: "discover jemperli, a treatment option. find information about dosing, side effects, resources, and more."

Search DigitalStakeout Footprint to find another asset.

DMMR-ENDOMETRIAL-CANCER-TREATMENT.COM DNS Records

A Records

34.160.236.144

AAAA Records

No DNS AAAA records

TXT Records

No DNS TXT records

Search DigitalStakeout Footprint to find another asset.

DMMR-ENDOMETRIAL-CANCER-TREATMENT.COM Subdomains

dmmr-endometrial-cancer-treatment.com has 1 subdomains in our inventory.

Hostname IP Address
dmmr-endometrial-cancer-treatment.com 34.160.236.144

Search DigitalStakeout Footprint to find another asset.

DMMR-ENDOMETRIAL-CANCER-TREATMENT.COM Website

Web Server

Apache

IP Address

34.160.236.144

Country

United States

Meta Tags

og:image: /content/dam/cf-pharma/jemperli-v2/en_us/icons/jemperli-logo.jpg

og:type: website

og:url: https://jemperli.com/

og:description: discover jemperli, a treatment option. find information about dosing, side effects, resources, and more.

og:title: a treatment option | jemperli (dostarlimab-gxly)

Search DigitalStakeout Footprint to find another asset.

DMMR-ENDOMETRIAL-CANCER-TREATMENT.COM Certificate Trust

Certificate Trust Log

{"message_type": "certificate_update", "data": {"leaf_cert": {"not_after": 1708646399, "signature_algorithm": "sha256, rsa", "extensions": {"subjectKeyIdentifier": "48:FA:87:26:D8:E4:AB:BC:99:88:13:DD:F8:03:68:2F:66:40:40:76", "authorityKeyIdentifier": "keyid:17:D9:D6:25:27:67:F9:31:C2:49:43:D9:30:36:44:8C:6C:A9:4F:EB\n", "extendedKeyUsage": "TLS Web server authentication, TLS Web client authentication", "subjectAltName": "DNS:www.piavail.gsk.com, DNS:www.ipad-test.gsk.com, DNS:www.india-consumer.gsk.com, DNS:www.implementationscience.viivhealthcare.com, DNS:www.hivpractice.com, DNS:www.hiv-frueher-erkennen.de, DNS:www.helpwhoopingcough.com.au, DNS:www.gskusbenefitsoverview.com, DNS:www.gsk360km-dev.gsk.com, DNS:www.gsk360answers-dev.gsk.com, DNS:www.fr.triumeq.com, DNS:www.fr.tivicay.com, DNS:www.fr.dolutegravir.com, DNS:www.flu.gsk.com, DNS:www.esig-cloudlearning.gsk.com, DNS:www.es.viivexchange.com, DNS:www.es.tivicay.com, DNS:www.es.dolutegravir.com, DNS:www.eczanemukemmeliyeti.gsk.com, DNS:www.dtg3tc.viivhealthcare.com, DNS:www.dmmr-endometrial-cancer-treatment.com, DNS:www.dk.dolutegravir.com, DNS:www.diversity.gsk.com, DNS:www.de.triumeq.com, DNS:www.de.tivicay.com, DNS:www.de.dolutegravir.com, DNS:www.datashingrixic.com, DNS:www.covid-19rfp.viivhealthcare.com, DNS:www.copayapplication.com, DNS:www.conoceherpeszoster.mx, DNS:www.conoceherpeszoster.com.mx, DNS:www.conoceherpeszoster.com, DNS:www.concierge.viivhealthcare.com, DNS:www.comunidad-viiv.com, DNS:www.ch.triumeq.com, DNS:www.ch.tivicay.com, DNS:www.ch.dolutegravir.com, DNS:www.ca.triumeq.com, DNS:www.ca.tivicay.com, DNS:www.ca.dolutegravir.com, DNS:www.br.tivicay.com, DNS:www.be.triumeq.com, DNS:www.be.tivicay.com, DNS:www.be.dolutegravir.com, DNS:www.au.triumeq.com, DNS:www.au.tivicay.com, DNS:www.au.dolutegravir.com, DNS:www.ami-pe.gsk.com, DNS:www.ami-ec.gsk.com, DNS:piavail.gsk.com, DNS:india-consumer.gsk.com, DNS:implementationscience.viivhealthcare.com, DNS:hivpractice.com, DNS:hiv-frueher-erkennen.de, DNS:helpwhoopingcough.com.au, DNS:gskusbenefitsoverview.com, DNS:fr.triumeq.com, DNS:fr.tivicay.com, DNS:fr.dolutegravir.com, DNS:esig-cloudlearning.gsk.com, DNS:es.viivexchange.com, DNS:es.tivicay.com, DNS:es.dolutegravir.com, DNS:dtg3tc.viivhealthcare.com, DNS:dmmr-endometrial-cancer-treatment.com, DNS:dk.dolutegravir.com, DNS:de.triumeq.com, DNS:de.tivicay.com, DNS:de.dolutegravir.com, DNS:datashingrixic.com, DNS:covid-19rfp.viivhealthcare.com, DNS:copayapplication.com, DNS:conoceherpeszoster.mx, DNS:conoceherpeszoster.com.mx, DNS:conoceherpeszoster.com, DNS:concierge.viivhealthcare.com, DNS:comunidad-viiv.com, DNS:ch.triumeq.com, DNS:ch.tivicay.com, DNS:ch.dolutegravir.com, DNS:ca.triumeq.com, DNS:ca.tivicay.com, DNS:ca.dolutegravir.com, DNS:br.tivicay.com, DNS:be.triumeq.com, DNS:be.tivicay.com, DNS:be.dolutegravir.com, DNS:au.triumeq.com, DNS:au.tivicay.com, DNS:au.dolutegravir.com, DNS:ami-pe.gsk.com, DNS:ami-ec.gsk.com, DNS:rewrites.gskinternet.com", "crlDistributionPoints": "Full Name:\n URI:http://crl.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crl", "keyUsage": "Digital Signature, Key Encipherment", "certificatePolicies": "Policy: 2.23.140.1.2.2\nPolicy: 1.3.6.1.4.1.6449.1.2.1.3.4\n CPS: https://sectigo.com/CPS", "ctlPoisonByte": true, "authorityInfoAccess": "OCSP - URI:http://ocsp.sectigo.com\nCA Issuers - URI:http://crt.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crt\n", "basicConstraints": "CA:FALSE"}, "fingerprint": "FF:80:CD:A4:8D:87:21:F3:B3:07:E2:13:4B:FA:9C:76:2B:26:95:CD", "all_domains": ["rewrites.gskinternet.com", "www.conoceherpeszoster.com", "ami-pe.gsk.com", "piavail.gsk.com", "www.gskusbenefitsoverview.com", "es.viivexchange.com", "www.es.dolutegravir.com", "www.dtg3tc.viivhealthcare.com", "datashingrixic.com", "be.triumeq.com", "india-consumer.gsk.com", "www.be.tivicay.com", "www.helpwhoopingcough.com.au", "comunidad-viiv.com", "www.diversity.gsk.com", "www.gsk360answers-dev.gsk.com", "www.esig-cloudlearning.gsk.com", "www.de.tivicay.com", "de.tivicay.com", "es.dolutegravir.com", "www.hiv-frueher-erkennen.de", "www.concierge.viivhealthcare.com", "hivpractice.com", "de.dolutegravir.com", "dtg3tc.viivhealthcare.com", "ami-ec.gsk.com", "ch.dolutegravir.com", "www.datashingrixic.com", "www.be.dolutegravir.com", "ca.triumeq.com", "www.ami-ec.gsk.com", "covid-19rfp.viivhealthcare.com", "www.au.triumeq.com", "www.ca.tivicay.com", "www.comunidad-viiv.com", "conoceherpeszoster.mx", "www.br.tivicay.com", "www.flu.gsk.com", "www.implementationscience.viivhealthcare.com", "au.triumeq.com", "www.fr.tivicay.com", "www.dmmr-endometrial-cancer-treatment.com", "www.hivpractice.com", "es.tivicay.com", "implementationscience.viivhealthcare.com", "www.es.viivexchange.com", "ca.tivicay.com", "www.copayapplication.com", "www.fr.dolutegravir.com", "www.de.dolutegravir.com", "www.conoceherpeszoster.com.mx", "www.conoceherpeszoster.mx", "conoceherpeszoster.com.mx", "www.gsk360km-dev.gsk.com", "www.es.tivicay.com", "www.be.triumeq.com", "www.au.dolutegravir.com", "www.dk.dolutegravir.com", "be.dolutegravir.com", "fr.triumeq.com", "gskusbenefitsoverview.com", "www.ch.tivicay.com", "ca.dolutegravir.com", "www.au.tivicay.com", "www.ca.dolutegravir.com", "www.fr.triumeq.com", "au.tivicay.com", "www.covid-19rfp.viivhealthcare.com", "de.triumeq.com", "www.ch.dolutegravir.com", "au.dolutegravir.com", "fr.tivicay.com", "dk.dolutegravir.com", "esig-cloudlearning.gsk.com", "ch.tivicay.com", "be.tivicay.com", "fr.dolutegravir.com", "www.ch.triumeq.com", "www.eczanemukemmeliyeti.gsk.com", "www.ca.triumeq.com", "www.de.triumeq.com", "conoceherpeszoster.com", "ch.triumeq.com", "www.india-consumer.gsk.com", "br.tivicay.com", "www.piavail.gsk.com", "dmmr-endometrial-cancer-treatment.com", "www.ami-pe.gsk.com", "hiv-frueher-erkennen.de", "helpwhoopingcough.com.au", "www.ipad-test.gsk.com", "concierge.viivhealthcare.com", "copayapplication.com"], "serial_number": "5B026FDC2E9DC3936B5348DE084908B", "subject": {"C": "GB", "CN": "rewrites.gskinternet.com", "L": null, "O": "GlaxoSmithKline Holdings Ltd", "ST": "Middlesex", "emailAddress": null, "OU": null, "aggregated": "/C=GB/CN=rewrites.gskinternet.com/O=GlaxoSmithKline Holdings Ltd/ST=Middlesex"}, "not_before": 1677024000, "issuer": {"C": "GB", "CN": "Sectigo RSA Organization Validation Secure Server CA", "L": "Salford", "O": "Sectigo Limited", "ST": "Greater Manchester", "emailAddress": null, "OU": null, "aggregated": "/C=GB/CN=Sectigo RSA Organization Validation Secure Server CA/L=Salford/O=Sectigo Limited/ST=Greater Manchester"}}, "cert_link": "https://ct.googleapis.com/logs/eu1/xenon2024/ct/v1/get-entries?start=38466752&end=38466752", "source": {"url": "https://ct.googleapis.com/logs/eu1/xenon2024/", "name": "Google 'Xenon2024' log"}, "update_type": "PrecertLogEntry", "seen": 1677098214.029253, "cert_index": 38466752}}

Search DigitalStakeout Footprint to find another asset.